Patents by Inventor Shianlen Cahoon

Shianlen Cahoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for detecting compounds that modulate inflammatory responses
    Patent number: 7273712
    Abstract: The present invention relates to compositions and methods for identification and development of compounds or therapeutic agents that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to methods for detecting compounds or therapeutic agents that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in cells. The present invention provides compositions for and methods of treatment of biological conditions including, but not limited to, vascular complications of type I and type II diabetic induced vasculopathies, other vasculopathies, microangiopathies, renal insufficiency, Alzheimer's syndrome, and inflammation-induced diseases such as atherosclerosis.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: September 25, 2007
    Assignee: Reddy US Therapeutics, Inc.
    Inventors: Sivaram Pillarisetti, Shianlen Cahoon, Uday Saxena
  • Methods and compositions for the treatment of inflammatory diseases
    Patent number: 6900041
    Abstract: The present invention is directed to compositions and methods for treating inflammatory diseases comprising administration of compositions that effect glycogen synthase kinase 3? (GSK-3?) protein or gene. The present invention also comprises methods and compositions for the identification of compounds or therapeutic agents which modulate the activity of the protein. The present invention provides compositions for and methods off treatment of biological conditions including, but not limited to, type I and type II diabetic induced vasculopathy, other vasculopathies, asthma and inflammation-induced diseases such as atherosclerosis and cell proliferation.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: May 31, 2005
    Assignee: Reddy US Therapeutics Inc.
    Inventors: Shianlen Cahoon, Sivaram Pillarisetti, Uday Saxena, Angela Vines
  • Methods and compositions for detecting compounds that modulate inflammatory responses
    Publication number: 20020086282
    Abstract: The present invention relates to compositions and methods for identification and development of compounds or therapeutic agents that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to methods for detecting compounds or therapeutic agents that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in cells. The present invention provides compositions for and methods of treatment of biological conditions including, but not limited to, vascular complications of type I and type II diabetic induced vasculopathies, other vasculopathies, microangiopathies, renal insufficiency, Alzheimer's syndrome, and inflammation-induced diseases such as atherosclerosis.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 4, 2002
    Inventors: Sivaram Pillarisetti, Shianlen Cahoon, Uday Saxena
  • Methods and compositions for the treatment of inflammatory diseases
    Publication number: 20020077293
    Abstract: The present invention is directed to compositions and methods for treating inflammatory diseases comprising administration of compositions that effect glycogen synthase kinase 3&bgr; (GSK-3&bgr;) protein or gene. The present invention also comprises methods and compositions for the identification of compounds or therapeutic agents which modulate the activity of the protein. The present invention provides compositions for and methods off treatment of biological conditions including, but not limited to, type I and type II diabetic induced vasculopathy, other vasculopathies, asthma and inflammation-induced diseases such as atherosclerosis and cell proliferation.
    Type: Application
    Filed: October 2, 2001
    Publication date: June 20, 2002
    Inventors: Shianlen Cahoon, Sivaram Pillarisetti, Uday Saxena, Angela Vines